Robotic-assisted Percutaneous Access
1 other identifier
interventional
5
1 country
1
Brief Summary
This is a first-in-man (FIM) study to show feasibility and safety profile of the newly developed robotic device for percutaneous access in PCNL surgery. Patients with renal stone disease who had standard indications for prone PCNL were included in the study. PCNL was conducted with percutaneous puncture with the aid of robotic device with the use of intra-operative fluoroscopy. 5 patients were recruited in this pilot study over a period of 3 months. Punctures were performed by the board-qualified urologist.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2018
CompletedFirst Submitted
Initial submission to the registry
June 9, 2020
CompletedFirst Posted
Study publicly available on registry
June 17, 2020
CompletedJune 17, 2020
June 1, 2020
3 months
June 9, 2020
June 15, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Needle insertion time
Time taken for PCNL procedure
During procedure
Needle alignment time
Time taken for needle alignment
During procedure
Time to target
Time taken for the needle to reach the calyx, from on the skin to successful needle targeting
During procedure
Number of needle insertion attempts to obtain access
Number of attempts before successfully reaching the calyx
During procedure
Radiation dosage from placement of robot to efflux of urine
A measure of the radiation exposed during the surgical procedure
During procedure
Radiation dosage from placement of robot to successful needle target via image confirmation
A measure of the radiation exposed during the surgical procedure
During procedure
Study Arms (1)
PCNL with the aid of the robotic device
EXPERIMENTALPatients will undergo prone PCNL under fluoroscopic guidance and with the aid of the robotic device.
Interventions
During the surgery, the robot was positioned over the estimated insertion point. It was aligned to be parallel to the fluoroscope imaging plane as much as possible. The needle is to be placed through the holder, and slightly penetrate the surface of the skin. An x-ray image is then taken to ensure that the whole device can be seen on the screen. Image calibration is then performed through the software GUI. After which, the clinician is also to perform needle tip selection. After which, needle alignment will then be performed. Once needle alignment is complete, the clinician will then advance the trocar needle into the patient's body, using the fluoroscopy to judge the penetration depth. Once the target has been reached, the needle style is to be extracted. The indication of leakage of fluid through the outer needle confirms the success of the procedure.
Eligibility Criteria
You may qualify if:
- Age between 21 to 75 years
- Diagnosed with kidney stone disease and planned for prone PCNL with indication for surgery as per standard of care
- Subject who understand the purpose of testing, voluntary and informed consent, patients undergoing invasive imaging follow-up.
You may not qualify if:
- Bleeding disorders
- Patient on anticoagulation/antiplatelets drugs
- Pyonephrosis
- Pregnant women
- Not able to have prone position for the procedure due to comorbidities
- Moderate to severe renal failure
- The patient's life expectancy is less than 12 months
- Poor compliance and patients unable to complete the study in accordance with the requirements.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NDR Medical Technology Pte Ltdlead
- University of Malayacollaborator
Study Sites (1)
University Malaya Medical Centre
Kuala Lumpur, 59100, Malaysia
Related Publications (3)
Mozer P, Troccaz J, Stoianovici D. Urologic robots and future directions. Curr Opin Urol. 2009 Jan;19(1):114-9. doi: 10.1097/MOU.0b013e32831cc1ba.
PMID: 19057227BACKGROUNDCinquin P. How today's robots work and perspectives for the future. J Visc Surg. 2011 Oct;148(5 Suppl):e12-8. doi: 10.1016/j.jviscsurg.2011.08.003. Epub 2011 Oct 5. No abstract available.
PMID: 21981795BACKGROUNDOo MM, Gandhi HR, Chong KT, Goh JQ, Ng KW, Hein AT, Tan YK. Automated Needle Targeting with X-ray (ANT-X) - Robot-assisted device for percutaneous nephrolithotomy (PCNL) with its first successful use in human. J Endourol. 2021 Jun;35(6):e919. doi: 10.1089/end.2018.0003.
PMID: 29699415RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Patients will undergo prone PCNL under fluoroscopic guidance and with the aid of the robotic device. They will then be admitted to inpatient ward as per standard of care for PCNL.
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2020
First Posted
June 17, 2020
Study Start
August 7, 2018
Primary Completion
November 1, 2018
Study Completion
November 1, 2018
Last Updated
June 17, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share